Definitive Contract HHSO100201600022C

Award Date 8/24/16
Potential Completion Date 8/1/20
Potential Value $13M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Medford, NY 11763, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a $13,154,406.37 cost-plus-fixed-fee contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Chembio Diagnostic Systems Inc. for the development of a point-of-care Zika diagnostic assay using dual path platform technology. The contract has an ultimate completion date of August 1, 2020. Chembio Diagnostic Systems Inc. is a for-profit organization and manufacturer of rapid diagnostic tests that has received multiple federal contract awards from various HHS agencies for the supply of diagnostic test kits and research and development of detection technologies. No set-aside designation is mentioned for this award.

Generated 7/11/24, 10:00 AM